Developing a non-invasive pre-natal test to replace amniocentesis

Private

Early / 2010

Develops multiplexed, quantitative molecular diagnostic tests

Private

Early / 2009

Develops novel molecular diagnostics with broad applications in infectious disease

Private

Start-up / 2007

Developer of chip-based instruments and reagents for molecular diagnostics

Acquired by Becton Dickinson, 2006

Early / 2002

Development and manufacture of protein microarrays

Acquired by Invitrogen Corporation, 2004

Seed / 2001

Consumer focused applied genomics

IPO 2005

Start-up / 2000

Novel technologies for immunodiagnostics

Acquired by QIAGEN N.V., 2004

Start-up / 1998